These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23176150)

  • 41. Population pharmacokinetic analysis of meropenem in Japanese adult patients.
    Muro T; Sasaki T; Hosaka N; Umeda Y; Takemoto S; Yamamoto H; Kamimura H; Higuchi S; Karube Y
    J Clin Pharm Ther; 2011 Apr; 36(2):230-6. PubMed ID: 21366653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Excretion of antibiotics into the pancreatic juice].
    Slukhaĭ IuF; Kerasheva SI
    Vestn Khir Im I I Grek; 1983 Sep; 131(9):66-8. PubMed ID: 6649323
    [No Abstract]   [Full Text] [Related]  

  • 44. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man.
    Brattström C; Malmborg AS; Tydén G
    Surgery; 1988 May; 103(5):563-7. PubMed ID: 3283981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock.
    Karjagin J; Lefeuvre S; Oselin K; Kipper K; Marchand S; Tikkerberi A; Starkopf J; Couet W; Sawchuk RJ
    Clin Pharmacol Ther; 2008 Mar; 83(3):452-9. PubMed ID: 17687272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penetration of ciprofloxacin into the human pancreas.
    Isenmann R; Friess H; Schlegel P; Fleischer K; Büchler MW
    Infection; 1994; 22(5):343-6. PubMed ID: 7843813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
    Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL
    J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamics of meropenem in critically ill patients with ventilator-associated pneumonia.
    Jaruratanasirikul S; Kositpantawong N; Jullangkoon M; Aeinlang N; Wongpoowarak W
    J Med Assoc Thai; 2013 Oct; 96(10):1283-9. PubMed ID: 24350408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.
    Chou YW; Yang YH; Chen JH; Kuo CC; Chen SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):294-301. PubMed ID: 17625990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
    Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
    J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S
    J Antimicrob Chemother; 2003 Sep; 52(3):518-21. PubMed ID: 12917242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring.
    Tröger U; Drust A; Martens-Lobenhoffer J; Tanev I; Braun-Dullaeus RC; Bode-Böger SM
    Int J Antimicrob Agents; 2012 Oct; 40(4):370-2. PubMed ID: 22795654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.
    Tomaselli F; Maier A; Matzi V; Smolle-Jüttner FM; Dittrich P
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2228-32. PubMed ID: 15155226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration of imipenem into human pancreatic juice following single intravenous dose administration.
    Brattström C; Malmborg AS; Tydén G
    Chemotherapy; 1989; 35(2):83-7. PubMed ID: 2758871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice.
    Brattström C; Malmborg AS; Tydén G
    J Antimicrob Chemother; 1988 Aug; 22(2):213-9. PubMed ID: 3053553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of the penetration of meropenem into bile using endoscopic retrograde cholangiography.
    Granai F; Smart HL; Triger DR
    J Antimicrob Chemother; 1992 Jun; 29(6):711-8. PubMed ID: 1506351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and Assessment of a Nomogram to Propose the Initial Dosage Regimen of a Meropenem Infusion Based on Serum Creatinine and Age Using a Monte Carlo Simulation.
    Shino N; Uchida T; Yoshida M; Nomura Y
    Chem Pharm Bull (Tokyo); 2015; 63(12):986-91. PubMed ID: 26633021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostatic penetration of meropenem after intravenous administration in patients undergoing transurethral resection of the prostate.
    Yamada Y; Ikawa K; Nakamura K; Mitsui K; Narushima M; Hibi H; Ikeda K; Morikawa N; Honda N
    J Chemother; 2011 Jun; 23(3):179-80. PubMed ID: 21742590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.